INVIVYD INC
IVVD · NASDAQ
Updated at 2026-10-15 08:21:07
- Today's High
- $0.64
- Today’s Low
- $0.60
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.64
- Previous Close
- $0.60
- Volume
- 3.99M
- Market Cap
- $179.15M
- P/E Ratio
- --
- EPS
- $-0.37
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 209 CHURCH STREET, NEW HAVEN, CT, UNITED STATES, 06510
- Country
- US
- Listing Date
- 2021-08-06
- Fiscal Year End
- December
- Shares Outstanding
- 294.61M
- CIK
- 0001832038
- Website
- invivyd.com
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases in the United States. The company is headquartered in Waltham, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$14.28M
2026-03-31
$13.74M
2025-12-31
$17.2M
2025-09-30
$13.12M
Operating Expenses
2026-06-30
$58.83M
2026-03-31
$55.33M
2025-12-31
$28.62M
2025-09-30
$23.06M
Net Income
2026-06-30
-$44.39M
2026-03-31
-$41.4M
2025-12-31
-$11.07M
2025-09-30
-$10.47M
Net Profit Margin
2026-06-30
-310.76%
2026-03-31
-301.22%
2025-12-31
-64.33%
2025-09-30
-79.74%
Earnings Per Share
2026-06-30
$-0.14
2026-03-31
$-0.13
2025-12-31
$-0.03
2025-09-30
$-0.06
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$45.1M
2026-03-31
-$40.88M
2025-12-31
-$10.63M
2025-09-30
-$10.03M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $14.28M | $13.74M | $17.2M | $13.12M |
| Operating Expenses | $58.83M | $55.33M | $28.62M | $23.06M |
| Net Income | -$44.39M | -$41.4M | -$11.07M | -$10.47M |
| Net Profit Margin | -310.76% | -301.22% | -64.33% | -79.74% |
| Earnings Per Share | $-0.14 | $-0.13 | $-0.03 | $-0.06 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$45.1M | -$40.88M | -$10.63M | -$10.03M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.